Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil

Vaccine

Volumn 30, Issue 37, 2012, Pages 5541-5546

  Cardoso, Cristiane W ^a,b   Pinto, Lorene Louise Silva ^c,d   Reis, Mitermayer G ^a,d   Flannery, Brendan ^e   Reis, Joice N ^a,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Municipal Secretary of Health of Salvador ^*  (Brazil)

^c Secretary of Health for the State of Bahia   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

Author keywords

Bacterial meningitis; Meningococcal vaccine; Neisseria meningitidis

Indexed keywords

MENINGOCOCCUS VACCINE; NEISVAS C; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BRAZIL; CHILD; DRUG EFFICACY; EPIDEMIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; MASS VACCINATION; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PROGRAM EVALUATION; VACCINATION; YOUNG ADULT;

EID: 84864303922     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.044     Document Type: Article

References (22)

1. de Moraes J.C., Barata R.B. Meningococcal disease in Sao Paulo, Brazil, in the 20th century: epidemiological characteristics. Cad Saude Publica 2005, 21(September-October (5)):1458-1471.
2. Fonseca C.M.J., Barata R. O livro da meningite uma doença sob a luz da cidade 2004, Segmento Farma, São Paulo.
3. de Lemos A.P., Yara T.Y., Gorla M.C., de Paiva M.V., de Souza A.L., Goncalves M.I., et al. Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil. J Clin Microbiol 2007, 45(April (4)):1266-1273.
4. Harrison L.H., Trotter C.L., Ramsay M.E. Global epidemiology of meningococcal disease. Vaccine 2009, 27(June (Suppl. 2)):B51-B63.
5. Epidemiologic Surveillance Department Epidemiological bulletin 2010, Epidemiologic Surveillance Department, Salvador, Bahia. Bahia State Health Department (Ed.).
6. Brasil. Secretaria de Saúde do Estado da Bahia. Relatório de Gestão SESAB 2010; 2010, p. 21, Available from: [cited 09.07.2011]. http://www.saude.ba.gov.br/2010.
7. Cordeiro S.M., Neves A.B., Ribeiro C.T., Petersen M.L., Gouveia E.L., Ribeiro G.S., et al. Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil. Trans R Soc Trop Med Hyg 2007, 101(November (11)):1147-1153.
8. Wedege E., Hoiby E.A., Rosenqvist E., Froholm L.O. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 1990, 31(March (3)):195-201.
9. Farrington C.P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993, 22(August (4)):742-746.
10. Snape M.D., Pollard A.J. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005, 5(January (1)):21-30.
11. Cano R., Larrauri A., Mateo S., Alcala B., Salcedo C., Vazquez J.A. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision. Euro Surveill 2004, 9(July (7)):11-15.
12. de Greeff S.C., de Melker H.E., Spanjaard L., Schouls L.M., van Derende A. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006, 25(January (1)):79-80.
13. Trotter C.L., Andrews N.J., Kaczmarski E.B., Miller E., Ramsay M.E. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004, 364(July (9431)):365-367.
14. Miller E., Salisbury D., Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2001, 20(October (Suppl. 1)):S58-S67.
15. Brooks R., Woods C.W., Benjamin D.K., Rosenstein N.E. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 2006, 43(July (1)):49-54.
16. Whalen C.M., Hockin J.C., Ryan A., Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 1995, 273(February (5)):390-394.
17. Mooney J.D. Conjugate vaccine is highly effective for controlling epidemics of meningococcus C infection in young people. Evid Based Healthc Public Health 2005, 9:200-202.
18. Teixeira A.M., Samad S.A., Souza M.A., Segatto T.C., Morice A., Flannery B. Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaign. Rev Panam Salud Publica 2011, 30(July (1)):7-14.
19. Domingues C.M., de Oliveira W.K. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil. Vaccine 2012, 30(July (6)):4744-4751.
20. Harrison L.H. Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis 2010, 50(March (Suppl. 2)):S37-S44.
21. Caugant D.A. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998, 106(May (5)):505-525.
22. Cohn A.C., MacNeil J.R., Harrison L.H., Hatcher C., Theodore J., Schmidt M., et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2009, 50(January (2)):184-191.